11:06 AM EST - MediPharm Labs Corp. : Today announced its financial results for the three months ended March 31, 2026. Net Revenue of $9 Million with strong gross margins of 37%. Adjusted EBITDA of $0.1 million is an improvement from negative $0.1 million in Q4 2025, reflecting margin quality and lower operating expenses. MediPharm Labs Corp.
shares T.LABS are trading up $0.01 at $0.09.
